Medacta Group SA Total Liabilities
Medacta Group SA total liabilities. Based on the latest financial reports, Medacta Group SA (MOVE) has total liabilities worth CHF436.15 Million CHF (≈ $551.42 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Medacta Group SA to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Medacta Group SA (2015–2024)
Total liabilities of Medacta Group SA from 2015 to 2024. This chart illustrates how Medacta Group SA's total liabilities have evolved over time, based on quarterly financial data. Explore MOVE long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Medacta Group SA Competitors by Total Liabilities
The table below lists competitors of Medacta Group SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cal-Maine Foods Inc
NASDAQ:CALM
|
USA | $467.04 Million |
|
Applied Opt
NASDAQ:AAOI
|
USA | $419.44 Million |
|
ABM Industries Incorporated
NYSE:ABM
|
USA | $3.81 Billion |
|
Kiatnakin Phatra Bank Public Company Limited
BK:KKP
|
Thailand | ฿431.25 Billion |
|
China Southern Power Grid Technology Co Ltd
SHG:688248
|
China | CN¥1.45 Billion |
|
Beijing Capital Co Ltd
SHG:600008
|
China | CN¥69.03 Billion |
|
Colbun
SN:COLBUN
|
Chile | CL$3.63 Billion |
|
Vietjet Aviation JSC
VN:VJC
|
Vietnam | ₫114.61 Trillion |
Liability Composition Analysis (2015–2024)
This chart breaks down Medacta Group SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Medacta Group SA assets under control.
Liquidity & Leverage Metrics
Medacta Group SA Total Liabilities Ratios Explained
Medacta Group SA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medacta Group SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medacta Group SA (2015–2024)
The table below shows the annual total liabilities of Medacta Group SA from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CHF412.51 Million ≈ $521.53 Million |
+12.76% |
| 2023-12-31 | CHF365.83 Million ≈ $462.51 Million |
+18.07% |
| 2022-12-31 | CHF309.83 Million ≈ $391.71 Million |
+17.87% |
| 2021-12-31 | CHF262.87 Million ≈ $332.34 Million |
-5.18% |
| 2020-12-31 | CHF277.22 Million ≈ $350.48 Million |
-4.19% |
| 2019-12-31 | CHF289.33 Million ≈ $365.79 Million |
+4.63% |
| 2018-12-31 | CHF276.53 Million ≈ $349.60 Million |
+39.56% |
| 2017-12-31 | CHF198.14 Million ≈ $250.50 Million |
+61.34% |
| 2016-12-31 | CHF122.81 Million ≈ $155.27 Million |
+11.35% |
| 2015-12-31 | CHF110.29 Million ≈ $139.44 Million |
-- |
About Medacta Group SA
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.